CONRAD B. BLUM, M.D.; RICHARD J. HAVLIK, M.D.; JOEL MORGANROTH, M.D.
Nine patients with familial hypercholesterolemia (type II hyperlipoproteinemia) and two normal volunteers were studied to ascertain the effectiveness of cholestyramine in lowering plasma cholesterol when a twice-a-day dosage regimen was compared with the same total dosage administered four times a day. The study showed that in these subjects the two regimens were equally effective. The ability to administer cholestyramine twice daily in working adults and school children should greatly enhance adherence to this agent.
BLUM CB, HAVLIK RJ, MORGANROTH J. Cholestyramine: An Effective, Twice-Daily Dosage Regimen. Ann Intern Med. ;85:287–289. doi: 10.7326/0003-4819-85-3-287
Download citation file:
Published: Ann Intern Med. 1976;85(3):287-289.
Cardiology, Coronary Risk Factors, Dyslipidemia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use